Edgewell Personal Care Earnings: What To Look For From EPC

Edgewell Personal Care (NYSE: EPC) is set to report earnings Wednesday before the bell. Last quarter, it met revenue expectations with $519.5 million, flat year over year, and beat analysts on EBITDA and organic revenue. For the upcoming quarter, analysts expect 3% revenue growth after a 13.5% decline. The average analyst price target is $28 versus $27.61.

Original reporting
Published Aug 4, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 4:38 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Edgewell Personal Care Earnings: What To Look For From EPC — source image
Decision brief

The 30-second read

$EPCNeutralMed
01

Why it matters

Traders can use the stated consensus revenue growth (3% YoY) and the prior-quarter beat framing to gauge whether the upcoming print is likely to surprise on revenue and profitability metrics.

02

Market read

This is primarily an earnings preview with consensus expectations and peer read-through, offering a timing-based catalyst rather than new company-specific information.

03

What to watch

The piece emphasizes revenue growth expectations and prior-quarter beats, but does not detail margins, cash flow, or segment drivers that typically determine post-earnings repricing.

Relevance 4/10Novelty 4/10Timing: pre-market earnings this Wednesday

Background

EPC is scheduled to report earnings this Wednesday before the bell; the article summarizes the prior quarter and the current consensus setup.

Company-level read

Ticker impact

$EPCNeutralMedium confidence
Context

Edgewell Personal Care (EPC) reports earnings this Wednesday before the bell, with prior-quarter revenue at $519.5M and flat YoY.

Expected impact

Likely volatility around the pre-bell print, with upside if revenue growth and EBITDA/organic trends match or exceed the prior-quarter beats.

Evidence & confidence

No new guidance or fresh datapoint is disclosed beyond recap-style prior results and consensus expectations; the tradable element is the scheduled earnings timing plus the stated expectation reversal.

Market effects

Consumer staples earnings read-through is referenced via peers, but without new EPC-specific fundamentals beyond the earnings setup.

None specified.

None specified.

Counterpoint

Because the article provides no new EPC guidance or incremental disclosures, the market may already be positioned for consensus, limiting follow-through unless results materially beat or guide differently.

Key entities

  • Edgewell Personal Care

    Subject of the article, scheduled to report earnings this Wednesday before the bell.

  • Medifast

    Peer mentioned for Q2 revenue performance as a read-through example.

  • Vita Coco

    Peer mentioned for Q2 revenue performance and subsequent stock reaction as a read-through example.

Related articles

$EPCMed

How Edgewell’s Revenue Miss and Margin Pressure Will Impact Edgewell Personal Care (EPC) Investors

Edgewell Personal Care (EPC) reported Q2 revenue up 1.7% YoY but missed estimates, with organic revenue and EBITDA also below forecasts. Management highlighted adjusted EPS and EBITDA beating expectations, but weaker margins and EPS momentum raised concerns. The company affirmed its dividend while lowering full-year EPS guidance, focusing on cash generation amid profitability scrutiny. Analysts project $2.0B revenue and $769.1M earnings by 2029, with a 11% upside to current price.

$EPCMedAI 8/10

Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% reported and 1.1% organic, with North America organic growth of 3.0% and international down 1.4% due to Middle East and supply disruptions. Adjusted EPS was $0.72. Full-year guidance: organic net sales flat to 0.5%, adjusted EPS $1.80-$2.00, EBITDA $250-$260 million.

$EPCMedAI 8/10

Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% on a 1.1% organic increase. Adjusted EPS was $0.72, flat year over year. Adjusted EBITDA fell to $78.9 million. Management cited North America organic growth of 3.0% and a 1.4% international decline from Middle East and supply disruptions. Full-year organic sales guidance is flat to +0.5%, adjusted EPS $1.80-$2.00.

$EPCMedAI 8/10

Edgewell Personal Care Q3 Earnings Call Highlights

Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.

$EPCMed

Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results

Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.